DOI:
10.1055/s-00000036
Laryngo-Rhino-Otologie
LinksClose Window
References
Garcia G, Magnan A, Chiron R, Contin-Bordes C, Berger P, Taillé C, Devouassoux G, de Blay F, Couderc LJ, Didier A, O’Callaghan DS, Girodet PO, Bourdeix I, Le Gros V, Humbert M.
A proof-of-concept, randomized, controlled trial of omalizumab in patients with severe, difficult-to-control, nonatopic asthma.
Chest 2013;
144: 411-419
We do not assume any responsibility for the contents of the web pages of other providers.